학술논문

Long-term Safety and Tolerability of Ozanimod by Age Category in Patients With Relapsing Multiple Sclerosis From Two Phase 3 Trials and an Open-Label Extension Study
Document Type
Journal
Source
MULTIPLE SCLEROSIS JOURNAL; MAY 2023, 29 p56-p57, 2p. Supplement: 2
Subject
Language
English
ISSN
14770970